JAK inhibitors

Tips and Tricks for Diagnosing & Managing Atopic Dermatitis (AD)
atopic dermatitis
by Edita Newton, MD on
Atopic dermatitis is a heterogeneous, chronic inflammatory disease that affects upwards of 10% of children and 7% of adults in the United States. Despite being an incredibly common skin concern among patients, AD continues to pose diagnostic and treatment challenges to dermatologists. What are some common misconceptions about AD? AD always starts in childhood. FALSE. 25% of adults w …
What’s New in Atopic Dermatitis
atopic dermatitis
by NEXT STEPS IN DERM TEAM on
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Adam Friedman (Professor and Chair of Dermatology who serves as Associate Residency Program Director, Director of Translational Research, and Director of the Supportive Oncodermatology Program in the GW Department of Dermatology) about the latest in Atopic Dermatitis (AD). Watch as he discu …
Easing the Management of Atopic Dermatitis
Atopic Dermatitis
by Jacqueline McKesey, MD, MS on
Dr. Friedman, jack of many trades, Professor and Interim Chair of Dermatology at George Washington University provided an excellent overview of ways to achieve victory over atopic dermatitis (AD). This expert discussion took place during the ODAC Inflammatory Diseases Symposium on December 3, 2020. How could we possibly cover atopic dermatitis in 20 minutes? Well, Dr. Friedman skillfully led us …
Inhibiting the JAK/STAT Pathway to Treat Inflammatory Skin Diseases
JAK Inhibitors
by NEXT STEPS IN DERM TEAM on
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Jonathan Zippin, Vice-Chair of Research and an Associate Attending Dermatologist and Associate Professor of Dermatology at Weill Medical College of Cornell, and Director of the Contact, Occupational and Photodermatitis Service. Watch as he reviews the JAK/STAT signaling pathway in normal i …
Coronavirus & Alopecia Reporting Database
coronavirus alopecia database
by Dmitri Wall, MD on
EPI Health has graciously supported the COVID-19 News and Resource Center. SECURE-Alopecia is a physician-entered patient registry to record COVID-19 positive alopecia patient outcomes, on or off treatment, with scarring and non-scarring alopecia. Clinicians worldwide are encouraged to report ALL cases of COVID-19 in their alopecia patients treated with antimalarials, JAK inhibitors (given the …